Sickle Cell Disease Transplant Using a Nonmyeloablative Approach for Patients With Anti-donor Red Cell Antibody | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Sickle Cell Disease Transplant Using a Nonmyeloablative Approach for Patients With Anti-donor Red Cell Antibody	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, anemia, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, sickle cell disease	Recruiting	Phase 2	2025-09-26		NCT06358638

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Alberta Children's Hospital	18
Ann & Robert H Lurie Children's Hospital of Chicago	76
Children's Hospital at Montefiore	6
Children's National Research Institute	84
Doris Duke Charitable Foundation	18
Janssen Pharmaceuticals	24
Levine Children's Hospital	2
Nationwide Children's Hospital	97
The Hospital for Sick Children	162

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Children's National Hospital	Washington D.C.	United States	100